Literature DB >> 3036684

Current pathogenetic concepts of diffuse malignant mesothelioma.

J E Craighead.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036684     DOI: 10.1016/s0046-8177(87)80354-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  7 in total

1.  Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats.

Authors:  J E Craighead; N J Akley; L B Gould; B L Libbus
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

2.  Desmoplastic malignant mesothelioma: a review of 17 cases.

Authors:  G E Wilson; P S Hasleton; A K Chatterjee
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

3.  Telomerase activity in human pleural mesothelioma.

Authors:  K Dhaene; R Hübner; S Kumar-Singh; B Weyn; E Van Marck
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

4.  Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.

Authors:  Wen-Bin Ou; Christopher Hubert; Joseph M Corson; Raphael Bueno; Daniel L Flynn; David J Sugarbaker; Jonathan A Fletcher
Journal:  Neoplasia       Date:  2011-01       Impact factor: 5.715

5.  Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology.

Authors:  P Harvey; A Warn; S Dobbin; N Arakaki; Y Daikuhara; M C Jaurand; R M Warn
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

6.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Multipoint targeting of the PI3K/mTOR pathway in mesothelioma.

Authors:  S Zhou; L Liu; H Li; G Eilers; Y Kuang; S Shi; Z Yan; X Li; J M Corson; F Meng; H Zhou; Q Sheng; J A Fletcher; W-B Ou
Journal:  Br J Cancer       Date:  2014-04-24       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.